Immunoreactivity of JR-141 found in brain in TFRC-KI/Ids-KO mice. Phase I/II clinical trial of JR-141 for mucopolysaccharidosis II (MPSII) currently underway. Here, TFRC is linked to mucopolysaccharidosis type 2.